Regulations.gov document
Memorandum re Nonprescription Drug Product With an Additional Condition for…
Other · FDA-2021-N-0862 · posted Jan 23, 2025
Key facts
| Document ID | FDA-2021-N-0862-0228 |
|---|---|
| Title | Memorandum re Nonprescription Drug Product With an Additional Condition for Nonprescription Use (Final Rule) |
| Document type | Other |
| Subtype | Memo |
| Agency | FDA |
| Docket | FDA-2021-N-0862 |
| Posted | Jan 23, 2025 |
| Comment period opens | Jan 23, 2025 |
| Effective date | Oct 17, 2022 |
At a glance
- 100–999 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: